Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Asan Digestive Disease Research Institute, Seoul, South Korea.
Gastrointest Endosc. 2011 May;73(5):881-9, 889.e1-2. doi: 10.1016/j.gie.2010.12.028. Epub 2011 Mar 9.
Endoscopic resection in patients with superficial esophageal squamous carcinoma (SESC) is limited by the presence of lymph node metastasis (LNM), highlighting the importance of determining which patients have virtually no risk of LNM.
To investigate the clinicopathological parameters predicting LNM in patients who underwent esophagectomy for SESCs and to identify the best candidate patients for endoscopic resection.
Retrospective, single-center study.
Tertiary-care center.
A total of 190 patients who underwent esophagectomy for SESCs between 1991 and 2009.
Esophagectomy with lymph node dissection.
LNM.
Of 190 patients, 39 (20.5%) had LNM. The rates of LNM in patients with m1, m2, m3, sm1, sm2, and sm3 lesions were 0.0% (0/18), 8.7% (4/46), 25.0% (6/24), 15.0% (3/20), 26.0% (7/27), and 37.3% (19/51), respectively. On multivariate analysis, lymphovascular invasion (LVI) (P<.001), superficial tumor size (P=.004), and lower LMM (lamina muscularis mucosae) invasion width (P<.001) were independent predictors of LNM in patients with SESC invading the LMM. Among 63 patients with mucosal or sm1 cancer 3 cm or smaller, only 1 had LNM without LVI showing a lower LMM invasion width greater than 3.0 mm.
Retrospective analysis.
Endoscopic resection should be performed for mucosal cancer of 3 cm or less without positive lymph nodes. Moreover, if pathological examination of the endoscopically resected specimens shows invasion of the sm1 layer and a lower LMM invasion width of 3.0 mm or less, indicating an absence of LVI, the patient can be carefully observed without additional treatment.
内镜下切除治疗早期食管鳞癌(SESC)受淋巴结转移(LNM)的限制,突出了确定哪些患者几乎没有发生 LNM 风险的重要性。
探讨食管切除术治疗 SESC 患者中预测 LNM 的临床病理参数,并确定最适合内镜切除的患者。
回顾性、单中心研究。
三级医疗中心。
1991 年至 2009 年间接受食管切除术治疗的 190 例 SESC 患者。
食管切除术伴淋巴结清扫。
LNM。
在 190 例患者中,39 例(20.5%)有 LNM。m1、m2、m3、sm1、sm2 和 sm3 病变患者的 LNM 发生率分别为 0.0%(0/18)、8.7%(4/46)、25.0%(6/24)、15.0%(3/20)、26.0%(7/27)和 37.3%(19/51)。多变量分析显示,淋巴管浸润(LVI)(P<.001)、浅表肿瘤大小(P=.004)和较低的黏膜肌层(lamina muscularis mucosae,LMM)浸润宽度(P<.001)是 SESC 侵犯 LMM 患者发生 LNM 的独立预测因子。在 63 例黏膜或 sm1 癌 3cm 或更小的患者中,仅有 1 例无 LVI 且 LMM 浸润宽度大于 3.0mm 的患者发生 LNM。
回顾性分析。
对于无阳性淋巴结的 3cm 或更小的黏膜癌,应进行内镜下切除。此外,如果内镜切除标本的病理检查显示侵犯 sm1 层且 LMM 浸润宽度小于或等于 3.0mm,且无 LVI,则可以仔细观察患者,无需额外治疗。